De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report

Here, the authors identify and validate the emergence of a SARS-CoV-2 resistance mutation to Remdesivir, associated with virological recrudesce in an immunocompromised patient with persistent COVID-19.

Bibliographic Details
Main Authors: Shiv Gandhi, Jonathan Klein, Alexander J. Robertson, Mario A. Peña-Hernández, Michelle J. Lin, Pavitra Roychoudhury, Peiwen Lu, John Fournier, David Ferguson, Shah A. K. Mohamed Bakhash, M. Catherine Muenker, Ariktha Srivathsan, Elsio A. Wunder, Nicholas Kerantzas, Wenshuai Wang, Brett Lindenbach, Anna Pyle, Craig B. Wilen, Onyema Ogbuagu, Alexander L. Greninger, Akiko Iwasaki, Wade L. Schulz, Albert I. Ko
Format: Article
Language:English
Published: Nature Portfolio 2022-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-29104-y
_version_ 1811273503535529984
author Shiv Gandhi
Jonathan Klein
Alexander J. Robertson
Mario A. Peña-Hernández
Michelle J. Lin
Pavitra Roychoudhury
Peiwen Lu
John Fournier
David Ferguson
Shah A. K. Mohamed Bakhash
M. Catherine Muenker
Ariktha Srivathsan
Elsio A. Wunder
Nicholas Kerantzas
Wenshuai Wang
Brett Lindenbach
Anna Pyle
Craig B. Wilen
Onyema Ogbuagu
Alexander L. Greninger
Akiko Iwasaki
Wade L. Schulz
Albert I. Ko
author_facet Shiv Gandhi
Jonathan Klein
Alexander J. Robertson
Mario A. Peña-Hernández
Michelle J. Lin
Pavitra Roychoudhury
Peiwen Lu
John Fournier
David Ferguson
Shah A. K. Mohamed Bakhash
M. Catherine Muenker
Ariktha Srivathsan
Elsio A. Wunder
Nicholas Kerantzas
Wenshuai Wang
Brett Lindenbach
Anna Pyle
Craig B. Wilen
Onyema Ogbuagu
Alexander L. Greninger
Akiko Iwasaki
Wade L. Schulz
Albert I. Ko
author_sort Shiv Gandhi
collection DOAJ
description Here, the authors identify and validate the emergence of a SARS-CoV-2 resistance mutation to Remdesivir, associated with virological recrudesce in an immunocompromised patient with persistent COVID-19.
first_indexed 2024-04-12T23:00:22Z
format Article
id doaj.art-9b3a77f831774145b06a422bbfb8f3de
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-12T23:00:22Z
publishDate 2022-03-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-9b3a77f831774145b06a422bbfb8f3de2022-12-22T03:13:04ZengNature PortfolioNature Communications2041-17232022-03-011311810.1038/s41467-022-29104-yDe novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case reportShiv Gandhi0Jonathan Klein1Alexander J. Robertson2Mario A. Peña-Hernández3Michelle J. Lin4Pavitra Roychoudhury5Peiwen Lu6John Fournier7David Ferguson8Shah A. K. Mohamed Bakhash9M. Catherine Muenker10Ariktha Srivathsan11Elsio A. Wunder12Nicholas Kerantzas13Wenshuai Wang14Brett Lindenbach15Anna Pyle16Craig B. Wilen17Onyema Ogbuagu18Alexander L. Greninger19Akiko Iwasaki20Wade L. Schulz21Albert I. Ko22Section of Infectious Diseases, Department of Medicine, Yale University School of MedicineDepartment of Immunobiology, Yale University School of MedicineDepartment of Epidemiology of Microbial Diseases, Yale School of Public HealthDepartment of Immunobiology, Yale University School of MedicineDepartment of Laboratory Medicine, University of Washington School of MedicineDepartment of Laboratory Medicine, University of Washington School of MedicineDepartment of Immunobiology, Yale University School of MedicineSection of Infectious Diseases, Department of Medicine, Yale University School of MedicineCenter for Outcomes Research and Evaluation, Yale New Haven HospitalDepartment of Laboratory Medicine, University of Washington School of MedicineDepartment of Epidemiology of Microbial Diseases, Yale School of Public HealthDepartment of Epidemiology of Microbial Diseases, Yale School of Public HealthDepartment of Epidemiology of Microbial Diseases, Yale School of Public HealthDepartment of Laboratory Medicine, Yale School of MedicineDepartment of Molecular, Cellular and Developmental Biology, Yale UniversityDepartment of Microbial Pathogenesis, Yale School of MedicineDepartment of Molecular, Cellular and Developmental Biology, Yale UniversityDepartment of Immunobiology, Yale University School of MedicineSection of Infectious Diseases, Department of Medicine, Yale University School of MedicineDepartment of Laboratory Medicine, University of Washington School of MedicineDepartment of Immunobiology, Yale University School of MedicineCenter for Outcomes Research and Evaluation, Yale New Haven HospitalSection of Infectious Diseases, Department of Medicine, Yale University School of MedicineHere, the authors identify and validate the emergence of a SARS-CoV-2 resistance mutation to Remdesivir, associated with virological recrudesce in an immunocompromised patient with persistent COVID-19.https://doi.org/10.1038/s41467-022-29104-y
spellingShingle Shiv Gandhi
Jonathan Klein
Alexander J. Robertson
Mario A. Peña-Hernández
Michelle J. Lin
Pavitra Roychoudhury
Peiwen Lu
John Fournier
David Ferguson
Shah A. K. Mohamed Bakhash
M. Catherine Muenker
Ariktha Srivathsan
Elsio A. Wunder
Nicholas Kerantzas
Wenshuai Wang
Brett Lindenbach
Anna Pyle
Craig B. Wilen
Onyema Ogbuagu
Alexander L. Greninger
Akiko Iwasaki
Wade L. Schulz
Albert I. Ko
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
Nature Communications
title De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
title_full De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
title_fullStr De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
title_full_unstemmed De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
title_short De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
title_sort de novo emergence of a remdesivir resistance mutation during treatment of persistent sars cov 2 infection in an immunocompromised patient a case report
url https://doi.org/10.1038/s41467-022-29104-y
work_keys_str_mv AT shivgandhi denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT jonathanklein denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT alexanderjrobertson denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT marioapenahernandez denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT michellejlin denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT pavitraroychoudhury denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT peiwenlu denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT johnfournier denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT davidferguson denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT shahakmohamedbakhash denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT mcatherinemuenker denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT arikthasrivathsan denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT elsioawunder denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT nicholaskerantzas denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT wenshuaiwang denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT brettlindenbach denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT annapyle denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT craigbwilen denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT onyemaogbuagu denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT alexanderlgreninger denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT akikoiwasaki denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT wadelschulz denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport
AT albertiko denovoemergenceofaremdesivirresistancemutationduringtreatmentofpersistentsarscov2infectioninanimmunocompromisedpatientacasereport